Patents by Inventor Thomas Agersten Poulsen

Thomas Agersten Poulsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alpha-amylases
    Patent number: 9139822
    Abstract: The present invention relates to alpha-amylases, nucleic acids encoding the alpha-amylases, methods of producing the alpha-amylases, and methods of using the alpha-amylases.
    Type: Grant
    Filed: October 28, 2013
    Date of Patent: September 22, 2015
    Assignee: NOVOZYMES A/S
    Inventors: Carsten Andersen, Thomas Agersten Poulsen
  • ALPHA-AMYLASES
    Publication number: 20150225708
    Abstract: The present invention relates to alpha-amylases, nucleic acids encoding the alpha-amylases, methods of producing the alpha-amylases, and methods of using the alpha-amylases.
    Type: Application
    Filed: April 27, 2015
    Publication date: August 13, 2015
    Inventors: Carsten Andersen, Thomas Agersten Poulsen
  • Protease Variants
    Publication number: 20150218545
    Abstract: The present invention relates to proteases having at least 75% identity to a protease derived from Thermoascus aurantiacus and comprises at least one modification in the amino acid sequence thereof. These protease variants have improved thermostability. The invention also relates to DNA encoding these proteases, methods of their production, as well as the use thereof.
    Type: Application
    Filed: April 20, 2015
    Publication date: August 6, 2015
    Inventors: Tomoko Matsui, Allan Noergaard, Thomas Agersten Poulsen, John Matthews
  • Protease variants
    Patent number: 9040280
    Abstract: The present invention relates to proteases having at least 75% identity to a protease derived from Thermoascus aurantiacus and comprises at least one modification in the amino acid sequence thereof. These protease variants have improved thermostability. The invention also relates to DNA encoding these proteases, methods of their production, as well as the use thereof.
    Type: Grant
    Filed: December 10, 2010
    Date of Patent: May 26, 2015
    Assignee: NOVOZYMES A/S
    Inventors: Tomoko Matsui, Allan Noergaard, Thomas Agersten Poulsen, John Matthews
  • Alpha-Amylases
    Publication number: 20140075601
    Abstract: The present invention relates to alpha-amylases, nucleic acids encoding the alpha-amylases, methods of producing the alpha-amylases, and methods of using the alpha-amylases.
    Type: Application
    Filed: October 28, 2013
    Publication date: March 13, 2014
    Applicant: NOVOZYMES A/S
    Inventors: Carsten Andersen, Thomas Agersten Poulsen
  • Alpha-amylases
    Patent number: 8591969
    Abstract: The present invention relates to alpha-amylases, nucleic acids encoding the alpha-amylases, methods of producing the alpha-amylases, and methods of using the alpha-amylases.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: November 26, 2013
    Assignee: Novozymes A/S
    Inventors: Carsten Andersen, Thomas Agersten Poulsen
  • Alpha-amylases
    Patent number: 8435577
    Abstract: The present invention relates to alpha-amylases, nucleic acids encoding the alpha-amylases, methods of producing the alpha-amylases, and methods of using the alpha-amylases.
    Type: Grant
    Filed: January 4, 2011
    Date of Patent: May 7, 2013
    Assignee: Novozymes A/S
    Inventors: Carsten Andersen, Thomas Agersten Poulsen
  • Alpha-Amylase Variants and Polynucleotides Encoding Same
    Publication number: 20120282658
    Abstract: The present invention relates to variants of a parent alpha-amylase. The present invention also relates to polynucleotides encoding the variants and to nucleic acid constructs, vectors, and host cells comprising the polynucleotides, and methods of using the variant enzymes.
    Type: Application
    Filed: January 4, 2011
    Publication date: November 8, 2012
    Applicants: NOVOZYMES NORTH AMERICA, INC., NOVOZYMES A/S
    Inventors: Carsten Andersen, Randall Deinhammer, Thomas Agersten Poulsen, Miguel Duarte Toscano, Peter Kamp Hansen, Henrik Friis-Madsen, Anders Viksoe-Nielsen, Signe Eskildsen Larsen, Lars L.H. Christensen
  • Alpha-Amylases
    Publication number: 20120270267
    Abstract: The present invention relates to alpha-amylase variants, polynucleotides encoding the variants and nucleic acid constructs, vectors, and host cells comprising the polynucleotides, and methods of using the variant enzymes.
    Type: Application
    Filed: January 4, 2011
    Publication date: October 25, 2012
    Applicant: NOVOZYMES A/S
    Inventors: Carsten Andersen, Thomas Agersten Poulsen
  • Alpha-Amylases
    Publication number: 20120264176
    Abstract: The present invention relates to alpha-amylases, nucleic acids encoding the alpha-amylases, methods of producing the alpha-amylases, and methods of using the alpha-amylases.
    Type: Application
    Filed: January 4, 2011
    Publication date: October 18, 2012
    Applicant: Novozymes A/S
    Inventors: Carsten Andersen, Thomas Agersten Poulsen
  • Alpha-Amylases
    Publication number: 20120258497
    Abstract: The present invention relates to alpha-amylase variants, polynucleotides encoding the variants and nucleic acid constructs, vectors, and host cells comprising the polynucleotides, and methods of using the variant enzymes.
    Type: Application
    Filed: January 4, 2011
    Publication date: October 11, 2012
    Applicants: NOVOZYMES NORTH AMERICA, INC., NOVOZYMES A/S
    Inventors: Carsten Andersen, Thomas Agersten Poulsen
  • Expression of Genes from Gram Negative Bacteria in Fungi
    Publication number: 20100261259
    Abstract: The present invention provides a method for the recombinant expression of polypeptides originating from gram negative bacteria, in a fungal host suitable for industrial production. In a first aspect the present invention relates to a method for recombinant expression of a polypeptide from a gram negative bacterium in a fungal host cell, comprising the steps: i) providing a nucleic acid sequence encoding the polypeptide, said nucleic acid sequence comprising a first nucleic acid sequence encoding a fungal signal peptide and a second nucleic acid sequence encoding the polypeptide, having at least one modified codon, wherein the modification does not change the amino acid encoded by said codon and the nucleic acid sequence of said codon is different compared to the corresponding codon in the wild type nucleic acid sequence present in the said gram negative bacterium; ii) expressing the modified nucleic acid sequence in the fungal host.
    Type: Application
    Filed: August 3, 2007
    Publication date: October 14, 2010
    Applicant: Novozymes A/S
    Inventors: Tomoko Matsui, Pia Francke Johannesen, Shinobu Takagi, Thomas Agersten Poulsen, Noriko Tsutsumi, Zheng Liu, XiangYu Kong
  • Recombinant Production of Serum Albumin
    Publication number: 20090280534
    Abstract: The present invention relates to modified nucleotide sequences encoding serum albumin, wherein the mRNA sequence has been codon optimized for expression in a filamentous host cell. Furthermore the present invention relates to serum albumin produced in filamentous fungi or loaded by contacting serum albumin with an extract of a filamentous fungi culture. In an-other aspect the present invention relates to the use of said serum albumin in serum free cell culture media and also to a method of drying and agglomerating serum albumin thereby im-proving wettability and dispersability.
    Type: Application
    Filed: December 22, 2005
    Publication date: November 12, 2009
    Applicant: Novozymes A/S
    Inventors: Bjarke Christensen, Carsten Hjort, Thomas Agersten Poulsen, Poul Bach